No. 519: Baseball returns, Cape Canaveral launches and aquafarmers take a closer look – plus, a real Moon bounce

  Here’s the pitch: It’s Friday, dear readers, and you’ve completed yet another sultry summertime workweek – with a special bonus to boot. For the first time this entire pandemic, you can spend your weekend watching balls and strikes and dingers and diving stops, as greedy, aggravating and eternally glorious Major League Baseball makes its long-awaited return. Of course, the Mets’ rotation is already a shambles, so it appears the universe remains in working order….

For lupus patients, a possible ACE in the hole

By GREGORY ZELLER // A common pharmaceutical treatment for hypertension could be the key to preserving brain function in lupus patients. So says data published this month in the Journal of Experimental Medicine by an international team of scientists led by the redoubtable Betty Diamond, head of the Feinstein Institute for Medical Research’s Center for Autoimmune, Musculoskeletal and Hematopoietic Diseases and a professor of molecular medicine at the Donald and Barbara Zucker School of Medicine…

Feinstein ‘risk index’ could get the jump on lupus

By GREGORY ZELLER // A complex research effort led by top Feinstein Institute scientists has opened the door to a wide range of early-intervention protocols for the dreaded disease lupus. A Feinstein Institute for Medical Research team led by immunologist and Professor Betty Diamond has developed a system for identifying a person’s risk for lupus by examining antibodies and a specific protein complex found in the blood. Ideally, scientists may use these unique markers to…